The contract regulatory affairs-management services market for medical devices is estimated to be worth USD 820 million by 2030, growing at a CAGR of 6.9%, claims Roots Analysis

Over the years, outsourcing has become a popular trend with the medical device industry, allowing innovators to leverage the technical and regulatory expertise of contract service providers in order to expedite time to market

Roots Analysis is pleased to announce the publication of its recent study, titled, “Medical Device CROs for Regulatory Affairs Management Market, 2019-2030.”

The report features a detailed study on the current landscape of contract service providers focused on regulatory affairs management for medical devices. The study features an in-depth analysis, highlighting the capabilities of the various CROs engaged in this domain, across different regions of the globe. Amongst other elements, the report includes:

• A detailed review of the current market landscape of the medical devices regulatory affairs outsourcing market, featuring a list of over 400 CROs engaged in this domain.
• A detailed discussion on the need for regulatory review / oversight across different stages of the medical devices supply chain, with emphasis on the optimization of the supply chain using upcoming tools / technologies.
• An elaborate discussion on the various guidelines established by major regulatory bodies for medical device approval across North America, Europe, Asia-Pacific and rest of the world.
• Elaborate profiles of popular players that specialize in offering end-to-end regulatory services for medical devices across key geographies.
• A benchmark analysis, highlighting the key focus areas of very small-sized, small-sized, mid-sized and large companies, comparing their existing capabilities within and beyond their respective peer groups.
• An elaborate discussion on the various outsourcing business models adopted for regulatory affairs management, along with an insightful Harvey ball analysis of key considerations that need to be assessed by industry stakeholders while selecting a CRO partner.
• An analysis highlighting the key performance indicators used by sponsor companies to evaluate service providers that are active in the domain, based on information gathered via secondary research (for top-ten medical device players) and primary research.
• A survey analysis featuring inputs solicited from various experts who are directly / indirectly involved in providing regulatory affairs management services to medical device developers.
• A detailed market forecast, featuring analysis of the current and projected future opportunity across key market segments (listed below)
• Medical Device Class
• Class I
• Class II
• Class III
• Therapeutic Area
• Cardiovascular Disorders
• CNS Disorders
• Metabolic Disorders
• Oncological Disorders
• Ophthalmological Disease
• Orthopedic Disorders
• Pain Disorders
• Respiratory Disorders
• Others
• Type of Regulatory Affairs Service
• Pharmacies GAP-Analysis
• Pharmacies Legal Representation
• Pharmacies Notified Body Selection
• Product Labelling-related Services
• Product Registration and Clinical Trial Applications
• Regulatory Document Submissions
• Regulatory Writing and Publishing
• Risk Management-related Services
• Technical Dossier Set-up
• Vigilance & Medical Device Report
• Key Geographical Regions
• North America
• Europe
• Asia-Pacific and Rest of the World

Key companies covered in the report

• CTI Clinical Trial and Consulting Services
• CROMSOURCE
• ICON
• Intertek
• Medpace
• MIC Medical
• North American Science Associates (NAMSA)
• Parexel
• PharmaLex
• Premier Research 
• Société Générale de Surveillance (SGS)
• Underwriters Laboratory (UL)

For more information please click on the following link

https://www.rootsanalysis.com/reports/view_document/med-dev-regulatory/282.html  

Other Recent Offerings

1. Viral Vectors, Non-Viral Vectors and Gene Therapy Manufacturing Market (3rd Edition), 2019-2030
2. Medical Device Labels Manufacturing Market, 2019-2030
3. Medical Device Contract Manufacturing Market, 2019-2030

About Roots Analysis

Roots Analysis is one of the fastest growing market research companies, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. If you’d like help with your growing business needs, get in touch at info@rootsanalysis.com

Related Post
The gene therapy market is estimated to be worth USD 11.6 billion in 2030, predicts Roots Analysis
The continuous manufacturing market is estimated to be worth around USD 2 billion in 2030, predicts Roots Analysis
The ophthalmic drugs contract manufacturing market is estimated to be worth USD 1.7 billion in 2030, predicts Roots Analysis
The global handheld ultrasound imaging devices market is projected to be over USD 1.1 billion by 2030, growing at a CAGR of 11%, claims Roots Analysis
Cancer biomarkers market for TMB, MSI / MMR and TILs is estimated to be worth USD 860 million in 2030, predicts Roots Analysis

Contact Information:

Contact:
Gaurav Chaudhary
gaurav.chaudhary@rootsanalysis.com

Roots Analysis
A430, 4th Floor,
Bestech Business Towers, Sector 66, Mohali, India
sales@rootsanalysis.com
+1 (415) 800 3415
+44 (122) 391 1091
Web: https://www.rootsanalysis.com/
LinkedIn: https://in.linkedin.com/company/roots-analysis
Twitter: https://twitter.com/RootsAnalysis